Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
zoledronic acid (zometa) (1 trial)
carfilzomib (kyprolis) (1 trial)
cladribine (leustatin) (1 trial)
daratumumab (darzalex) (1 trial)
dexamethasone (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
rituximab (rituxan) (1 trial)
docetaxel (taxotere) (1 trial)
imatinib (gleevec) (1 trial)
Back Pain (Phase 3)
Breast Neoplasms (Phase 2)
Fractures, Bone (Phase 4)
Fractures, Stress (Phase 4)
Low Back Pain (Phase 3)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 3)
Sclerosis (Phase 3)
Trials (6 total)
Trial APIs (9 total)